Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02761187 · OUTCOME

Sites of Disease Diagnosed With ND MM and R/R MM

An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants · Source last updated 2025-02-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Baseline up to 5 years

Analysis population: As the study was early terminated data was not collected for this outcome measure.

Groups in this outcome

NDMM

Participants newly diagnosed with MM within 3 months from initiation of treatment were enrolled for 3 years, and followed for at least 2 years, until death, or the end of the study, whichever comes first (up to approximately 5 years).

RRMM

Participants diagnosed with RRMM who previously received 1 to 3 prior lines of therapy were enrolled for 3 years, and followed for at least 2 years, until death, or the end of the study, whichever comes first (up to approximately 5 years).

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
NDMM0
RRMM0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
calculate Pct
false
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    2. group Id
      OG001
      value
      0
    units
    Participants
groups
  1. description
    Participants newly diagnosed with MM within 3 months from initiation of treatment were enrolled for 3 years, and followed for at least 2 years, until death, or the end of the study, whichever comes first (up to approximately 5 years).
    id
    OG000
    title
    NDMM
  2. description
    Participants diagnosed with RRMM who previously received 1 to 3 prior lines of therapy were enrolled for 3 years, and followed for at least 2 years, until death, or the end of the study, whichever comes first (up to approximately 5 years).
    id
    OG001
    title
    RRMM
population Description
As the study was early terminated data was not collected for this outcome measure.
reporting Status
POSTED
time Frame
Baseline up to 5 years
title
Sites of Disease Diagnosed With ND MM and R/R MM
type
PRIMARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice